You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Summary of drug benefits 2003–2004: unrestricted and restricted coverage groups

From: The impact of generic-only drug benefits on patients' use of inhaled corticosteroids in a Medicare population with asthma

Coverage group 2003 2004
Unrestricted Coverage $10 generic copayment $10 generic copayment
  $15–25 brand copayment $15–25 brand copayment
Restricted Coverage $10 generic copayment $10 generic copayment
  $30 brand copayment No brand coverage (i.e., full-price for brands)
  $1,000 annual drug benefit cap No annual drug benefit cap